| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ... The American Journal of Human Genetics 72 (5), 1117-1130, 2003 | 4714 | 2003 |
| Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1306 | 2017 |
| Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019 | 897 | 2019 |
| Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies XR Yang, J Chang-Claude, EL Goode, FJ Couch, H Nevanlinna, RL Milne, ... Journal of the National Cancer Institute 103 (3), 250-263, 2011 | 837 | 2011 |
| Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy T Byrski, J Gronwald, T Huzarski, E Grzybowska, M Budryk, M Stawicka, ... Journal of Clinical Oncology 28 (3), 375-379, 2010 | 721 | 2010 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 645 | 2013 |
| CHEK2 is a multiorgan cancer susceptibility gene C Cybulski, B Gorski, T Huzarski, B Masojć, M Mierzejewski, T Dębniak, ... The American Journal of Human Genetics 75 (6), 1131-1135, 2004 | 619 | 2004 |
| The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions AC Antoniou, AP Cunningham, J Peto, DG Evans, F Lalloo, SA Narod, ... British journal of cancer 98 (8), 1457-1466, 2008 | 612 | 2008 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 546 | 2015 |
| Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients T Byrski, T Huzarski, R Dent, J Gronwald, D Zuziak, C Cybulski, J Kladny, ... Breast cancer research and treatment 115, 359-363, 2009 | 457 | 2009 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 415 | 2013 |
| International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers KA Metcalfe, D Birenbaum‐Carmeli, J Lubinski, J Gronwald, H Lynch, ... International journal of cancer 122 (9), 2017-2022, 2008 | 411 | 2008 |
| A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general … AC Antoniou, X Wang, ZS Fredericksen, L McGuffog, R Tarrell, ... Nature genetics 42 (10), 885-892, 2010 | 406 | 2010 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 392 | 2017 |
| A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 EL Goode, G Chenevix-Trench, H Song, SJ Ramus, M Notaridou, ... Nature genetics 42 (10), 874-879, 2010 | 390 | 2010 |
| Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population H Song, E Dicks, SJ Ramus, JP Tyrer, MP Intermaggio, J Hayward, ... Journal of Clinical Oncology 33 (26), 2901, 2015 | 379 | 2015 |
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 351 | 2017 |
| Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update J Gronwald, N Tung, WD Foulkes, K Offit, R Gershoni, M Daly, C Kim‐Sing, ... International journal of cancer 118 (9), 2281-2284, 2006 | 340 | 2006 |
| Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients T Byrski, T Huzarski, R Dent, E Marczyk, M Jasiówka, J Gronwald, ... Breast cancer research and treatment 147, 401-405, 2014 | 339 | 2014 |
| A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22. 2 H Song, SJ Ramus, J Tyrer, KL Bolton, A Gentry-Maharaj, E Wozniak, ... Nature genetics 41 (9), 996-1000, 2009 | 339 | 2009 |
